NEW YORK (GenomeWeb News) – Single-cell technology firm Sphere Fluidics today announced the completion of a $2.5 million investment round.

24Haymarket led the round. Other investors included the Royal Society Enterprise Fund, Cambridge Enterprise, Providence Investment, the University of Cambridge Enterprise Fund, the London Business Angels Roundtable EIS Fund, and individual investors.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: rare variants linked to bleeding disorder, comparison of whole-exome and whole-genome sequencing, and more.

George Church tells The Sunday Times that his group has inserted some woolly mammoth genes into elephant cells.

A Scientific Reports editor resigns over a new policy at the journal allowing researchers to pay to fast track the peer review of their manuscripts, and poll.

The National Cancer Institute's Harold Varmus discusses the state of cancer research with the New York Times.